
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10450700
[patent_doc_number] => 20150335714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'USE OF HUMAN CHORIONIC GONADOTROPIN TO INHIBIT DEVELOPMENT OR MINIMIZE SEVERITY OF CEREBRAL PALSY AND/OR ITS CO-MORBIDITIES'
[patent_app_type] => utility
[patent_app_number] => 14/762983
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13996
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762983 | USE OF HUMAN CHORIONIC GONADOTROPIN TO INHIBIT DEVELOPMENT OR MINIMIZE SEVERITY OF CEREBRAL PALSY AND/OR ITS CO-MORBIDITIES | Jan 22, 2014 | Abandoned |
Array
(
[id] => 10905259
[patent_doc_number] => 20140308272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'TREATMENT OF PRION PROTEIN RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/158385
[patent_app_country] => US
[patent_app_date] => 2014-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17182
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14158385
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/158385 | TREATMENT OF PRION PROTEIN RELATED DISEASES | Jan 16, 2014 | Abandoned |
Array
(
[id] => 9464052
[patent_doc_number] => 20140128479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Absorption Enhancers for Drug Administration'
[patent_app_type] => utility
[patent_app_number] => 14/152686
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16530
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152686
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/152686 | Pharmaceutical composition including alkyl glycoside and an anti-seizure agent | Jan 9, 2014 | Issued |
Array
(
[id] => 10109204
[patent_doc_number] => 09144597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-29
[patent_title] => 'Use of liver growth factor (LGF) as a neural tissue regenerator'
[patent_app_type] => utility
[patent_app_number] => 14/140014
[patent_app_country] => US
[patent_app_date] => 2013-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6483
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14140014
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/140014 | Use of liver growth factor (LGF) as a neural tissue regenerator | Dec 23, 2013 | Issued |
Array
(
[id] => 9397001
[patent_doc_number] => 20140094407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/096493
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096493
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/096493 | DEVICES AND METHODS FOR TREATING AND/OR PREVENTING DISEASES | Dec 3, 2013 | Abandoned |
Array
(
[id] => 11330939
[patent_doc_number] => 09522172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'GM-CSF for use in the prevention of spontaneous abortion and embryo implantation failure'
[patent_app_type] => utility
[patent_app_number] => 14/648020
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3385
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648020 | GM-CSF for use in the prevention of spontaneous abortion and embryo implantation failure | Dec 2, 2013 | Issued |
Array
(
[id] => 9444951
[patent_doc_number] => 20140116118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'IPA AS A THERAPEUTIC AGENT, AS A PROTECTIVE AGENT, AND AS A BIOMARKER OF DISEASE RISK'
[patent_app_type] => utility
[patent_app_number] => 14/092677
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20823
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/092677 | IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease | Nov 26, 2013 | Issued |
Array
(
[id] => 12408561
[patent_doc_number] => 09969786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Trophic hormone fusion protein, preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 14/646926
[patent_app_country] => US
[patent_app_date] => 2013-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 10867
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646926
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646926 | Trophic hormone fusion protein, preparation method and application thereof | Nov 21, 2013 | Issued |
Array
(
[id] => 10450699
[patent_doc_number] => 20150335713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION'
[patent_app_type] => utility
[patent_app_number] => 14/443193
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5701
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443193 | SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION | Nov 14, 2013 | Abandoned |
Array
(
[id] => 11613707
[patent_doc_number] => 09651561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Diagnosis and treatment of endometriosis and related conditions'
[patent_app_type] => utility
[patent_app_number] => 14/443804
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 28835
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443804
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443804 | Diagnosis and treatment of endometriosis and related conditions | Nov 12, 2013 | Issued |
Array
(
[id] => 9383434
[patent_doc_number] => 20140086915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/073107
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13186
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073107
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073107 | AGENTS AND METHODS FOR MODULATING MACROPHAGE INHIBITORY CYTOKINE (MIC-1) ACTIVITY | Nov 5, 2013 | Abandoned |
Array
(
[id] => 9616164
[patent_doc_number] => 20140206021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'PRION PROTEIN LIGANDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/069052
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16872
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069052
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069052 | Prion protein ligands and methods of use | Oct 30, 2013 | Issued |
Array
(
[id] => 10380663
[patent_doc_number] => 20150265670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'AGENT FOR PREVENTING OR IMPROVING DECLINE IN BRAIN FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 14/435679
[patent_app_country] => US
[patent_app_date] => 2013-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5222
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435679 | Method of treating decline in brain function comprising coadministration of citrulline and glutathione | Oct 29, 2013 | Issued |
Array
(
[id] => 10408120
[patent_doc_number] => 20150293129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'DETECTION AND TREATMENT OF PREGNANCY COMPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/438033
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5375
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438033
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438033 | DETECTION AND TREATMENT OF PREGNANCY COMPLICATIONS | Oct 27, 2013 | Abandoned |
Array
(
[id] => 13142307
[patent_doc_number] => 10088480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Methods and compositions for assessing spermatozoa in a semen sample
[patent_app_type] => utility
[patent_app_number] => 14/436652
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 6487
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436652
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436652 | Methods and compositions for assessing spermatozoa in a semen sample | Oct 16, 2013 | Issued |
Array
(
[id] => 10353436
[patent_doc_number] => 20150238441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/433429
[patent_app_country] => US
[patent_app_date] => 2013-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7712
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433429
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433429 | Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases | Oct 6, 2013 | Abandoned |
Array
(
[id] => 9396111
[patent_doc_number] => 20140093517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'OXIDIZED LDL AS A BIOMARKER FOR NEUROLOGICAL COMPLICATIONS OF PREGNANCY'
[patent_app_type] => utility
[patent_app_number] => 14/045038
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15485
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045038
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045038 | Oxidized LDL as a biomarker for neurological complications of pregnancy | Oct 2, 2013 | Issued |
Array
(
[id] => 10365818
[patent_doc_number] => 20150250823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Preeclamptic Placental Mesenchymal Stem Cell Conditioned Medium for Use in the Treatment of a Tumour'
[patent_app_type] => utility
[patent_app_number] => 14/432722
[patent_app_country] => US
[patent_app_date] => 2013-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5178
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432722
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/432722 | Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour | Oct 1, 2013 | Issued |
Array
(
[id] => 9686633
[patent_doc_number] => 20140243398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'IRS MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/040137
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7990
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14040137
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/040137 | IRS MODULATORS | Sep 26, 2013 | Abandoned |
Array
(
[id] => 9222418
[patent_doc_number] => 20140017193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Methods for treating nervous system injury and disease'
[patent_app_type] => utility
[patent_app_number] => 14/028935
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22081
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028935 | Methods for treating nervous system injury and disease | Sep 16, 2013 | Abandoned |